Amylase Test

Amylase is an enzyme your body uses to break down starches into simpler sugars for digestion and energy. It is mainly produced by the salivary glands in your mouth and the pancreas in your abdomen, though smaller amounts are made in places like the lungs, muscles, and reproductive tissues. When you chew starchy foods like bread or rice, salivary amylase starts working right away, breaking down those complex carbohydrates in your mouth. After you swallow, the process continues in the small intestine with help from pancreatic amylase, which is optimized to work in the slightly alkaline environment of the duodenum, the first part of the small intestine.

There are two major types of amylase in your body: S-type, from saliva, and P-type, from the pancreas. These forms are encoded by different genes (AMY1 and AMY2), and the number of gene copies can vary among individuals. People from populations with historically starch-rich diets, such as those that practiced agriculture, often have more copies of the AMY1 gene and produce more salivary amylase—an adaptation that reflects the evolutionary importance of carbohydrate digestion. In fact, this variation in gene copy number contributes to wide differences in amylase activity among people.

Amylase works by cutting specific chemical bonds in starch molecules—specifically the α-1,4-glucosidic linkages—producing sugars like maltose and glucose. However, it cannot cut at the branch points of starch, so other enzymes are needed to finish the job. This means amylase starts digestion but doesn’t complete it on its own. After doing its work, amylase enters the bloodstream and is cleared mainly by the liver and kidneys. About a quarter of circulating amylase is filtered into the urine.

A significant rise in blood amylase, especially when combined with elevated lipase (another digestive enzyme), is often used to identify acute pancreatitis, an inflammation of the pancreas. However, amylase levels can also be high in many non-pancreatic conditions, such as salivary gland infections (like mumps), intestinal blockages, ovarian tumors, ruptured ectopic pregnancies, and even stress or trauma. A rare but benign condition called macroamylasemia occurs when amylase binds to larger proteins in the blood, forming a complex that’s too large for the kidneys to filter. This leads to persistently high blood amylase levels without symptoms or disease, and no treatment is required.

On the flip side, low amylase levels may point to chronic health issues like chronic pancreatitis, cystic fibrosis, type 2 diabetes, obesity, or even smoking-related pancreatic dysfunction. These low values might reflect a loss of enzyme-producing cells or a broader disruption of digestive health. In children under six months, pancreatic amylase is naturally very low because the pancreas hasn’t fully matured yet, so testing in infants can be misleading.

While amylase has historically been used to detect pancreatic disease, modern guidelines increasingly recommend lipase instead, because it remains elevated longer and is more specific to the pancreas. For example, in alcoholic pancreatitis or hypertriglyceridemia (very high blood fats), amylase may appear normal even when the pancreas is inflamed, whereas lipase usually rises. That said, amylase is still frequently ordered, especially in combination with lipase.

Amylase is also emerging as a potential biomarker in other areas of medicine. Researchers have explored its role in monitoring cancers, stress levels (via salivary amylase), and metabolic health. In people with type 2 diabetes and metabolic syndrome, lower serum amylase is often observed and may signal underlying dysfunction in the digestive or endocrine systems. Newer biosensors and rapid tests are even being developed to measure amylase levels in saliva, making it easier to monitor at home.